HK · Healthcare

Tong Ren Tang Technologies Co Ltd (1666)

Drug Manufacturers - General

Tong Ren Tang Technologies Co Ltd (1666) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-21, reported market cap is $4.76B, P/E ratio is 10.33, net margin is 6.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 1666

Market cap

$4.76B

P/E ratio

10.33

Gross profit (TTM)

$2.47B

Net margin

6.1%

Tong Ren Tang Technologies Co Ltd (1666) — FAQ

What is Tong Ren Tang Technologies Co Ltd's market cap?

Tong Ren Tang Technologies Co Ltd (1666) has a reported market cap of $4.76B (data as of 2026-05-21).

What is 1666's P/E ratio?

The price-to-earnings (P/E) ratio for Tong Ren Tang Technologies Co Ltd (1666) is 10.33 (data as of 2026-05-21).

Does Tong Ren Tang Technologies Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Tong Ren Tang Technologies Co Ltd (1666). Check the MyAverix Finance app for the latest dividend data.

What sector is Tong Ren Tang Technologies Co Ltd in?

Tong Ren Tang Technologies Co Ltd (1666) is classified in the Healthcare sector (Drug Manufacturers - General industry).

What exchange is 1666 listed on?

1666 is listed on HK.

What is Tong Ren Tang Technologies Co Ltd's net margin?

Tong Ren Tang Technologies Co Ltd (1666) reports a net margin of 6.1% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Aimed Bio (0009K0) Celltrion (068270) Rznomics (476830)